We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues CRL to Adamis Pharmaceuticals, Requests Human Factors And Reliability Data
FDA Issues CRL to Adamis Pharmaceuticals, Requests Human Factors And Reliability Data
A second FDA complete response letter to Adamis Pharmaceuticals for its acute anaphylaxis candidate requests an extension of its human factors and reliability studies.